Home | Blogs | Optimism for new targets of research

Optimism for new targets of research

idea.nottingham.ac.uk image: Dementia Day to Day blogs banner

dementia awareness, research

I am currently a final year student at the University of Nottingham studying Neuroscience. One of the major influences on my life that encouraged me to study the brain was my Grandad, who was diagnosed with Alzheimer’s Disease when I was incredibly young. I became increasingly interested in the mechanisms of the brain and how they may contribute to my Grandfather’s diagnosis. I was incredibly excited at the beginning of my second year when I enrolled onto a module called ‘Neurobiology of Disease’. During the module, I learnt about a variety of medical conditions, from ADHD to epilepsy and of course Alzheimer’s Disease.

As someone who has a close family member with Alzheimer’s, I found it somewhat comforting to learn that scientists and researchers have an impressively strong understanding of the symptoms of Alzheimer’s as well as it’s underpinning mechanisms.

We learnt that the main indicator of Alzheimer’s Disease is the presence of ‘Extracellular Amyloid Plaques’ in the brain. These are collections of the protein called Amyloid that are toxic to the brain and can disrupt the mechanisms by which cells in the brain are able to communicate with each other, they can also cause the loss of brain cells in a process called brain atrophy. 

Brain atrophy in the early stages of Alzheimer’s Disease, takes place in an area of the brain called the hippocampus. The hippocampus region of the brain is vital for memories and so by losing cells in this region forgetfulness can often incur. This loss of cells can progress causing the symptoms of Alzheimer’s appear increasingly severe and effect behaviour more and more.

The loss of cells as a reason for many symptoms of Alzheimer’s Disease provides researchers and scientists with a clear target for treatment. Brain cells can be lost for a variety of reasons, but with the Amyloid Plaques indicators, we know that in Alzheimer’s a big reason for cell loss is a fault in how the brain breaks down the proteins that form the Amyloid Plaques. This protein is referred to as APP and is present in every brain cell where it is normally used for repairing the cell it inhabits. When APP is cut into smaller pieces by certain sites of a cell it has a protective role, but when the APP is metabolised by other sites, known to scientists as the beta-secretase, the APP and this site form Amyloid. This Amyloid is what leaves the cells in the brain vulnerable, increases toxicity and disrupts the balance of chemicals in the cells.

Although this may appear a potentially daunting idea, it does provide hope to those researching Alzheimer’s Disease. With these biomarkers identified, diagnosis can occur much sooner and targeting the sites on cells that combine with APP to form these amyloid plaques is a clear target that scientists are concentrating their work on. 

Your comments

You'd be very welcome to leave a comment on this blog post. 

Your comment won't appear straight away as we'll need to check it first: thank you for your patience.

When leaving comments please bear in mind our posting rules.

Add new comment

This is for testing whether or not you are a human visitor and to prevent automated spam submissions.

See more like this

Karen Harrison Dening

I first became conscious of the concept of planning ahead for the end-of-life in the early 1990’s when I became a community psychiatric nurse (CPN) supporting families affected by dementia.  Over my 6 years as a CPN I was involved with several people with dementia

Zena Aldridge

Appearing in photo from left to righ are: Zena Aldridge (Admiral Nurse Research Fellow); Karen Harrison Dening (Head of Research & Publications, Dementia UK); Sue Lister, MBE, (AWOC) and Ann Murray (AWOC).

Eleri Clarke

My father was diagnosed with Alzheimer’s disease when I was 10, so I have always had some awareness of the condition.